Human pathology

Home page > D. Systemic pathology > Toxics and drugs > gefitinib

gefitinib

Gefitinib is an EGFR tyrosine kinase inhibitor.

References

- Herbst RS, Fukuoka M, Baselga J. Gefitinib—a novel targeted approach to treating cancer. Nat Rev Cancer. 2004 Dec;4(12):956-65. PMID: 15573117